StockData
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Trulieve Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)

Close on Oct 19, 2026

Market cap
$1.98B
P/E (TTM)
–
Dividend yield
–

About Trulieve Cannabis

Medicinal Chemicals & Botanical Products, SIC 2833

Trulieve Cannabis Corp. is a vertically integrated cannabis operator that cultivates, processes, manufactures, and distributes medical and adult-use cannabis products. The company produces cannabis flower, oils, and concentrates through extraction, distillation, and purification methods. It distributes these goods under proprietary brand tiers such as Avenue, Cultivar Collection, Muse, Modern Flower, Momenta, Sweet Talk, Co2lors, and Roll One, while also distributing partner brands. Trulieve serves qualified medical cannabis patients and recreational adult consumers aged 21 and older through retail dispensaries and wholesale channels.

The company concentrates its United States operations within three regional hubs located in the Southeast, Northeast, and Southwest. As of December 31, 2025, Trulieve operates 233 dispensaries and 15 cultivation and processing facilities across nine states, including Florida, Arizona, Pennsylvania, West Virginia, Ohio, Georgia, Maryland, Connecticut, and Colorado. The company's corporate head office is located in Tallahassee, Florida, with a registered office in Vancouver, British Columbia.

Summary of the business section of Trulieve Cannabis's latest annual report, written by StockData.

Company profile

Company

Legal name
Trulieve Cannabis Corp.
Founded
1940
Headquarters
Tallahassee, FL
Address
3494 Martin Hurst Road 32312
Phone
(850) 298-8866
Employees
5,000, Dec 31, 2025
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A1
Fiscal year ends
December 31
Auditor
Marcum LLP, West Palm Beach, FL

Stock & identifiers

Ticker
TRLV
Exchange
NYSE
IPO date
Apr 8, 2021
Shares outstanding
193M, Jul 31, 2026
Public float
$600.00M, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1754195
CUSIP
89788C104
ISIN
US89788C1045
EIN
58-1882476

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kim A. RiversChairman and CEO, Director1,476,913
Brett R. WalshChief Accounting Officer140,305
Christine Ann HerseyChief Corp Affairs & Strategy143,767
Jan ReeseChief Financial Officer58,594
Jason PernellPresident581,795
Nilyum JhalaChief Technology Officer246,254
Eric PowersChief Legal Officer246,311
Kyle LandrumChief Production Officer258,776
Timothy MoreyChief Sales Officer174,709
Joy MalivukChief Accounting Officer74,289
Gina CollinsChief Marketing Officer188,916
Ryan BlustInterim CFO77,038
Marie ZhangChief Operating Officer58,800
Wes GetmanChief Financial Officer47,000
Richard S. MayDirector593,534
Matthew J. FoulstonDirector34,767
Thomas L. MillnerDirector72,543
Susan ThronsonDirector74,283
Thad BeshearsDirector5,487,043
Jane Cecil MorreauDirector65,778
Peter HealyDirector72,673

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Kim Rivers
$7.59M$11.72M$879.87K$27$27
FY2024
Kim Rivers
$5.14M$3.49M$1.64M$16$22
FY2023
Kim Rivers
$3.36M$3.77M$682.28K$16$36
FY2022
Kim Rivers
$3.90M-$656.15K$1.36M$24$33
FY2021
Kim Rivers
$8.05M$7.14M$2.05M$82$79

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had over 5,000 employees.”

Corporate history

Events identified from SEC filings